Correspondence to “COVID-19-associated Pulmonary Aspergillosis: A Case Series” by Sharma et al.
Keywords :
Aspergillosis, COVID-19, Voriconazole
Citation Information :
Correspondence to “COVID-19-associated Pulmonary Aspergillosis: A Case Series” by Sharma et al.. Indian J Crit Care Med 2023; 27 (5):370-370.
Sharma S, Kujur R, Sharma K, Kumar N, Ray MK. Covid-19-associated pulmonary aspergillosis: A case series. Indian J Crit Care Med 2022;26(9):1039–1041. DOI: https://doi.org/10.5005/jp-journals-10071-24314.
Boonsarngsuk V, Niyompattama A, Teosirimongkol C, Sriwanichrak K. False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics. Scand J Infect Dis. 2010;42(6–7):461–468. DOI: 10.3109/00365541003602064.
Garg M, Prabhakar N, Muthu V, Farookh S, Kaur H, Suri V, et al. CT findings of COVID-19–associated pulmonary mucormycosis: A case series and literature review. Radiology 2022;302(1):214–247. DOI: 10.1148/radiol.2021211583.
Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis 2012;54(Suppl 1):S16–S22. DOI: 10.1093/cid/cir865.
Byrne AW, McEvoy D, Collins AB, Hunt K, Casey M, Barber A, et al. Inferred duration of infectious period of SARS-COV-2: Rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases. BMJ Open 2020;10(8). https://doi.org/10.1136/bmjopen-2020-039856.
